Developmental analysis and influence of genetic background on the Lhx3 W227ter mouse model of combined pituitary hormone deficiency disease

Endocrinology

Volumn 154, Issue 2, 2013, Pages 738-748

  Prince, Kelly L ^a   Colvin, Stephanie C ^a,b   Park, Soyoung ^a   Lai, Xianyin ^a   Witzmann, Frank A ^a   Rhodes, Simon J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLYCOPHORIN A; GROWTH HORMONE; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE BETA SUBUNIT; PITUITARY TRANSCRIPTIONAL ACTIVATOR 1; PROLACTIN; PROOPIOMELANOCORTIN; THYROTROPIN BETA SUBUNIT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LHX3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; COMBINED PITUITARY HORMONE DEFICIENCY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DEVELOPMENTAL STAGE; DISEASE SEVERITY; EMBRYO; FEMALE; GENETIC MODEL; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HORMONE SYNTHESIS; HYPOPHYSIS; HYPOPITUITARISM; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROTROPIN BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; HYPOPITUITARISM; LIM-HOMEODOMAIN PROTEINS; MICE; MICE, INBRED C57BL; PHENOTYPE; PITUITARY GLAND; PITUITARY HORMONES, ANTERIOR; PRO-OPIOMELANOCORTIN; PROLACTIN; PROTEOMICS; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS;

EID: 84872696293     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1790     Document Type: Article

References (58)

1. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT. Genetic regulation of pituitary gland development in human and mouse. Endocr Rev. 2009;30:790-829.
2. Davis SW, Castinetti F, Carvalho LR, et al. Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes. Mol Cell Endocrinol. 2010;323:4-19.
3. Mollard P, Hodson DJ, Lafont C, Rizzoti K, Drouin J. A tridimensional view of pituitary development and function. Trends Endocrinol Metab. 2012;23:261-269.
4. Prince KL, Walvoord EC, Rhodes SJ. The role of homeodomain transcription factors in heritable pituitary disease. Nat Rev Endocrinol. 2011;7:727-737.
5. Sharma K, Sheng HZ, Lettieri K, et al. LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell. 1998;95:817-828. (Pubitemid 29014461)
6. Sheng HZ, Zhadanov AB, Mosinger B Jr, et al. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science. 1996;272:1004-1007. (Pubitemid 26259316)
7. Sheng HZ, Moriyama K, Yamashita T, et al. Multistep control of pituitary organogenesis. Science. 1997;278:1809-1812. (Pubitemid 27527650)
8. Seidah NG, Barale JC, Marcinkiewicz M, Mattei MG, Day R, Chretien M. The mouse homeoprotein mLIM-3 is expressed early in cells derived from the neuroepithelium and persists in adult pituitary. DNA Cell Biol. 1994;13:1163-1180.
9. Bach I, Rhodes SJ, Pearse RV 2nd, et al. P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A. 1995;92:2720-2724.
10. Zhadanov AB, Bertuzzi S, Taira M, Dawid IB, Westphal H. Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dynam. 1995;202:354-364.
11. Granger A, Bleux C, Kottler ML, Rhodes SJ, Counis R, Laverriere JN. The LIM-homeodomain proteins Isl-1 and Lhx3 act with steroidogenic factor 1 to enhance gonadotrope-specific activity of the gonadotropin-releasing hormone receptor gene promoter. Mol Endocrinol. 2006;20:2093-2108. (Pubitemid 44286707)
12. McGillivray SM, Bailey JS, Ramezani R, Kirkwood BJ, Mellon PL. Mouse GnRH receptor gene expression is mediated by the LHX3 homeodomain protein. Endocrinology. 2005;146:2180-2185. (Pubitemid 40577504)
13. Sloop KW, Meier BC, Bridwell JL, Parker GE, Schiller AM, Rhodes SJ. Differential activation of pituitary hormone genes by human Lhx3 isoforms with distinct DNA binding properties. Mol Endocrinol. 1999;13:2212-2225. (Pubitemid 30637279)
14. West BE, Parker GE, Savage JJ, et al. Regulation of the follicle-stimulating hormone β gene by the LHX3 LIM-homeodomain transcription factor. Endocrinology. 2004;145:4866-4879. (Pubitemid 39551103)
15. Bonfig W, Krude H, Schmidt H. A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature. Eur J Pediatr. 2011;170:1017-1021.
16. Bhangoo AP, Hunter CS, Savage JJ, et al. Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab. 2006;91:747-753. (Pubitemid 43357733)
17. Kristrom B, Zdunek AM, Rydh A, Jonsson H, Sehlin P, Escher SA. A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations. J Clin Endocrinol Metab. 2009;94:1154-1161.
18. Netchine I, Sobrier ML, Krude H, et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet. 2000;25:182-186. (Pubitemid 30394989)
19. Pfaeffle RW, Savage JJ, Hunter CS, et al. Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. J Clin Endocrinol Metab. 2007;92:1909-1919. (Pubitemid 46997209)
20. Rajab A, Kelberman D, de Castro SC, et al. Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet. 2008;17:2150-2159. (Pubitemid 351911984)
21. Savage JJ, Hunter CS, Clark-Sturm SL, Jacob TM, Pfaeffle RW, Rhodes SJ. Mutations in the LHX3 gene cause dysregulation of pituitary and neural target genes that reflect patient phenotypes. Gene. 2007;400:44-51. (Pubitemid 47284732)
22. Sobrier ML, Attie-Bitach T, Netchine I, Encha-Razavi F, Vekemans M, Amselem S. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4expression during early human development. Gene Expr Patterns. 2004;5:279-284. (Pubitemid 39618939)
23. Bechtold-Dalla Pozza S, Hiedl S, Roeb J, et al. A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency. Horm Res Paediatr. 2012;77:41-51.
24. Colvin SC, Malik RE, Showalter AD, Sloop KW, Rhodes SJ. Model of pediatric pituitary hormone deficiency separates the endocrine and neural functions of the LHX3 transcription factor in vivo. Proc Natl Acad Sci U S A. 2011;108:173-178.
25. Voorbij AM, van Steenbeek FG, Vos-Loohuis M, Met al. A contracted DNA repeat in LHX3 intron 5 is associated with aberrant splicing and pituitary dwarfism in German shepherd dogs. PloS one. 2011;6:e27940.
26. Sobrier ML, Brachet C, Vie-Luton MP, et al. Symptomatic heterozygotes and prenatal diagnoses in a nonconsanguineous family with syndromic combined pituitary hormone deficiency resulting from two novel LHX3 mutations. J Clin Endocrinol Metab. 2012;97:E503-E509.
27. Sloop KW, Dwyer CJ, Rhodes SJ. An isoform-specific inhibitory domain regulates the LHX3 LIM homeodomain factor holoprotein and the production of a functional alternate translation form. J Biol Chem. 2001;276:36311-36319.
28. Voss JW, Yao TP, Rosenfeld MG. Alternative translation initiation site usage results in two structurally distinct forms of Pit-1. J Biol Chem. 1991;266:12832-12835. (Pubitemid 21907272)
29. Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, Witzmann FA. Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl. 2008;2:1140-1152.
30. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002;74:5383-5392. (Pubitemid 35215372)
31. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75:4646-4658. (Pubitemid 37082259)
32. Lai X, Wang L, Tang H, Witzmann FA. A novel alignment method and multiple filters for exclusion of unqualified peptides to enhance label-free quantification using peptide intensity in LC-MS/MS. J Proteome Res. 2011;10:4799-4812.
33. Storey JD. A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol. 2002;64:479-498.
34. Zhao Y, Mailloux CM, Hermesz E, Palkovits M, Westphal H. Arole of the LIM-homeobox gene Lhx2 in the regulation of pituitary development. Dev Biol. 2010;337:313-323.
35. Ellsworth BS, Butts DL, Camper SA. Mechanisms underlying pituitary hypoplasia and failed cell specification in Lhx3-deficient mice. Dev Biol. 2008;313:118-129. (Pubitemid 350298308)
36. Brinkmeier ML, Potok MA, Cha KB, et al. TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol. 2003;17:2152-2161. (Pubitemid 37352528)
37. Raetzman LT, Ward R, Camper SA. Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development. 2002;129:4229-4239.
38. Ward RD, Stone BM, Raetzman LT, Camper SA. Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol. 2006;20:1378-1390. (Pubitemid 43801238)
39. Cha KB, Douglas KR, Potok MA, Liang H, Jones SN, Camper SA. WNT5A signaling affects pituitary gland shape. Mech Dev. 2004;121:183-194. (Pubitemid 38368823)
40. Brinkmeier ML, Potok MA, Davis SW, Camper SA. TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol. 2007;311:396-407. (Pubitemid 350064370)
41. Kelberman D, Rizzoti K, Avilion A, et al. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest. 2006;116:2442-2455. (Pubitemid 44330143)
42. Sajedi E, Gaston-Massuet C, Signore M, et al. Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism. Dis Model Mech. 2008;1:241-254.
43. Zhao Y, Morales DC, Hermesz E, Lee WK, Pfaff SL, Westphal H. Reduced expression of the LIM-homeobox gene Lhx3 impairs growth and differentiation of Rathke's pouch and increases cell apoptosis during mouse pituitary development. Mech Dev. 2006;123:605-613. (Pubitemid 44308863)
44. Parker GE, Sandoval RM, Feister HA, Bidwell JP, Rhodes SJ. The homeodomain coordinates nuclear entry of the Lhx3 neuroendocrine transcription factor and association with the nuclear matrix. J Biol Chem. 2000;275:23891-23898. (Pubitemid 30624677)
45. Parker GE, West BE, Witzmann FA, Rhodes SJ. Serine/threonine/tyrosine phosphorylation of the LHX3 LIM-homeodomain transcription factor. J Cell Biochem. 2005;94:67-80. (Pubitemid 41420325)
46. Li S, Crenshaw EB 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 1990;347:528-533.
47. Lin SC, Li S, Drolet DW, Rosenfeld MG. Pituitary ontogeny of the Snell dwarf mouse reveals Pit-1-independent and Pit-1-dependent origins of the thyrotrope. Development. 1994;120:515-522. (Pubitemid 24071194)
48. Nasonkin IO, Ward RD, Raetzman LT, et al. Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet. 2004;13:2727-2735. (Pubitemid 39562539)
49. Ishola DA Jr, van der Giezen DM, Hahnel B, et al. In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant. 2006;21:591-597. (Pubitemid 43372903)
50. Robson MG, Cook HT, Pusey CD, Walport MJ, Davies KA. Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background. Clin Exp Immunol. 2003;133:326-333. (Pubitemid 37051504)
51. McCutcheon JE, Fisher AS, Guzdar E, Wood SA, Lightman SL, Hunt SP. Genetic background influences the behavioural and molecular consequences of neurokinin-1 receptor knockout. Eur J Neurosci. 2008;27:683-690. (Pubitemid 351239299)
52. Kelly MA, Rubinstein M, Asa SL, et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptordeficient mice. Neuron. 1997;19:103-113. (Pubitemid 27332997)
53. Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci. 2010;1214:57-69.
54. Gusella JF, MacDonald ME. Huntington's disease: the case for genetic modifiers. Genome Med. 2009;1:80.
55. Lee SK, Pfaff SL. Synchronization of neurogenesis and motor neuron specification by direct coupling of bHLH and homeodomain transcription factors. Neuron. 2003;38:731-745. (Pubitemid 36694780)
56. Thackray VG, Mellon PL, Coss D. Hormones in synergy: regulation of the pituitary gonadotropin genes. Mol Cell Endocrinol. 2010;314:192-203.
57. Chiamolera MI, Wondisford FE. Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology. 2009;150:1091-1096.
58. Gurr JA, Kourides IA. Regulation of thyrotropin biosynthesis. Discordant effect of thyroid hormone on alpha and beta subunit mRNA levels. J Biol Chem. 1983;258:10208-10211. (Pubitemid 14241173)